T Sein
Overview
Explore the profile of T Sein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sein T, Swe T, Toe M, Zaw K, Sein T
Indian J Cancer
. 2014 Dec;
51 Suppl 1:S3-7.
PMID: 25526245
Myanmar Tobacco Control Law of 2006 covers the control of all forms of tobacco use. After 7-year, tobacco use among adults did not see a decrease. The paper aimed to...
2.
Kyaing N, Sein T, Sein A, Than Htike M, Tun A, Shein N
Indian J Cancer
. 2013 Feb;
49(4):347-51.
PMID: 23442397
Smokeless tobacco (SLT) use in various forms is highly prevalent in Myanmar. The aim of this paper is to study the socio-cultural background of SLT use and products of SLT...
3.
Petraitiene R, Petraitis V, Groll A, Sein T, Piscitelli S, Candelario M, et al.
Antimicrob Agents Chemother
. 2001 Feb;
45(3):857-69.
PMID: 11181372
The antifungal efficacy, safety, and pharmacokinetics of posaconazole (SCH 56592) (POC) were investigated in treatment and prophylaxis of primary pulmonary aspergillosis due to Aspergillus fumigatus in persistently neutropenic rabbits. Antifungal...
4.
Petraitis V, Petraitiene R, Groll A, Sein T, Schaufele R, Lyman C, et al.
Antimicrob Agents Chemother
. 2001 Feb;
45(2):471-9.
PMID: 11158743
V-echinocandin (VER-002; LY303366) is a semisynthetic derivative of echinocandin B and a potent inhibitor of fungal (1, 3)-beta-D-glucan synthase. We studied the antifungal efficacy, the concentrations in saliva and tissue,...
5.
Roilides E, Sein T, Roden M, Schaufele R, Walsh T
J Infect Dis
. 2001 Jan;
183(3):518-20.
PMID: 11133388
No abstract available.
6.
Walsh T, Jackson A, Lee J, Amantea M, Sein T, Bacher J, et al.
Antimicrob Agents Chemother
. 2000 Jul;
44(8):2068-76.
PMID: 10898677
Amphotericin B lipid complex (ABLC) was recently approved by the Food and Drug Administration for treatment of patients with invasive fungal infections who are intolerant of or refractory to conventional...
7.
Roilides E, Lyman C, Sein T, Gonzalez C, Walsh T
Med Mycol
. 2000 May;
38(2):161-8.
PMID: 10817233
Disseminated infections due to Candida albicans are frequently encountered in immunocompromised patients. We compared the antifungal activities of macrophages residing in spleen, liver and lungs of rabbits against blastoconidia and...
8.
Petraitiene R, Petraitis V, Groll A, Candelario M, Sein T, Bell A, et al.
Antimicrob Agents Chemother
. 1999 Sep;
43(9):2148-55.
PMID: 10471556
The safety and antifungal activity of LY303366 (LY), a new broad-spectrum semisynthetic echinocandin, were studied against disseminated candidiasis in persistently neutropenic rabbits. In vitro time-kill assays demonstrated that LY has...
9.
Roilides E, Tsaparidou S, Kadiltsoglou I, Sein T, Walsh T
Infect Immun
. 1999 May;
67(6):3047-50.
PMID: 10338518
The potential of recombinant human interleukin-12 (IL-12) to enhance the capacity of human monocytes (MNC) to elicit an oxidative burst and damage hyphae of Aspergillus fumigatus was investigated. Incubation of...
10.
Roilides E, Sein T, Kadiltsoglou I, Walsh T
Infect Immun
. 1998 Nov;
66(12):5999-6003.
PMID: 9826384
Invasive aspergillosis is a serious complication in immunocompromised patients. The effects of recombinant human tumor necrosis factor alpha (TNF-alpha) on antifungal activities of human neutrophils (polymorphonuclear leukocytes [PMNs]), human monocytes...